Solventum Corporation (SOLV) Key Metrics
SOLV valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $14.61B
- Enterprise value
- $19.93B
- P/E (TTM)
- 10.5
- Forward P/E
- 13.1
- PEG ratio
- 1.22
- Price / sales
- 1.8
- Price / book
- 3.1
- EV / EBITDA
- 8.1
- Dividend yield
- —
- Beta
- 0.70
SOLV key metrics, 2020–2025
Fiscal year ended December 31, 2025 · U.S. dollarsSOLV valuation Price multiples at each fiscal year-end price.
SOLV returns How much profit the business earns on the capital it uses.
SOLV per-share figures Results divided by the shares outstanding at year-end.
SOLV financial health Debt, liquidity and how easily interest is covered.
SOLV efficiency & capital use Working capital cycle and where the cash goes.
SOLV valuation history
SOLV returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SOLV debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SOLV price vs earnings per share
SOLV key metrics
2020–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Market capitalization | $13.89B | $11.47B | — | — | — | — |
| Enterprise value | $18.05B | $18.72B | — | — | — | — |
| P/E ratio | 8.9 | 24.0 | — | — | — | — |
| Price / sales | 1.7 | 1.4 | — | — | — | — |
| Price / book | 2.8 | 3.9 | — | — | — | — |
| Price / free cash flow | — | 14.3 | — | — | — | — |
| Price / operating cash flow | 37.6 | 9.7 | — | — | — | — |
| EV / sales | 2.2 | 2.3 | — | — | — | — |
| EV / EBITDA | 7.1 | 12.3 | — | — | — | — |
| EV / free cash flow | — | 23.3 | — | — | — | — |
| Earnings yield | 11.2% | 4.2% | — | — | — | — |
| Free cash flow yield | −0.1% | 7.0% | — | — | — | — |
| Share price at fiscal year-end | $79.24 | $66.06 | — | — | — | — |
| Per share | ||||||
| Revenue per share | $47.49 | $47.52 | $47.46 | $47.14 | $47.38 | $42.22 |
| Earnings per share | $8.88 | $2.76 | $7.79 | $7.79 | $8.47 | $6.60 |
| Operating cash flow per share | $2.10 | $6.82 | $11.09 | $9.74 | $12.77 | $11.75 |
| Free cash flow per share | −$0.06 | $4.63 | $9.41 | $8.28 | $11.16 | $10.18 |
| Cash per share | $5.01 | $4.39 | $1.12 | $0.35 | $0.53 | — |
| Book value per share | $28.80 | $17.04 | $67.55 | $68.08 | $69.92 | — |
| Tangible book value per share | −$18.52 | −$34.32 | $12.91 | $11.92 | $10.04 | — |
| Capex per share | $2.16 | $2.19 | $1.68 | $1.46 | $1.61 | $1.57 |
| Debt per share | $28.72 | $46.11 | $48.07 | $0.55 | $0.65 | — |
| Shares outstanding | 175.3M | 173.7M | 172.7M | 172.5M | 172.5M | 172.5M |
| Change in shares outstanding | +0.9% | +0.6% | +0.1% | 0.0% | 0.0% | — |
| Returns & profitability | ||||||
| Return on equity (ROE) | 38.9% | 6.6% | 11.5% | 11.3% | 12.1% | — |
| Return on invested capital (ROIC) | 20.4% | 5.5% | 8.7% | 11.3% | 12.1% | — |
| Return on assets (ROA) | 10.8% | 3.4% | 9.8% | 9.7% | 10.4% | — |
| Return on tangible assets | 25.9% | 8.7% | 29.9% | 34.4% | 39.0% | — |
| Free cash flow margin | −0.1% | 9.8% | 19.8% | 17.6% | 23.6% | 24.1% |
| Income quality (OCF / net income) | 0.24 | 2.47 | 1.42 | 1.25 | 1.51 | 1.78 |
| Financial health | ||||||
| Total debt | $5.04B | $8.01B | $8.30B | $95.0M | $112.0M | — |
| Cash & short-term investments | $878.0M | $762.0M | $194.0M | $61.0M | $91.0M | — |
| Net debt | $4.16B | $7.25B | $8.11B | $34.0M | $21.0M | — |
| Debt / equity | 1.00 | 2.71 | 0.71 | 0.01 | 0.01 | — |
| Debt / assets | 0.35 | 0.55 | 0.60 | 0.01 | 0.01 | — |
| Net debt / EBITDA | 1.63 | 4.75 | 3.64 | 0.01 | 0.01 | — |
| Current ratio | 1.23 | 1.20 | 1.46 | 1.70 | 1.56 | — |
| Quick ratio | 0.89 | 0.84 | 0.96 | 1.04 | 0.98 | — |
| Interest coverage | 6.3 | 2.8 | — | — | — | — |
| Working capital | $723.0M | $546.0M | $791.0M | $920.0M | $783.0M | — |
| Invested capital | $9.21B | $10.21B | $19.77B | $11.78B | $12.08B | — |
| Tangible asset value | −$3.25B | −$5.96B | $2.23B | $2.06B | $1.73B | — |
| Net current asset value | −$5.39B | −$8.25B | $242.0M | $379.0M | $173.0M | — |
| Graham number | $75.84 | $32.51 | $108.83 | $109.22 | $115.40 | — |
| Graham net-net per share | −$40.27 | −$53.72 | −$3.88 | −$2.76 | −$3.69 | — |
| Capital allocation | ||||||
| Capex / revenue | 4.6% | 4.6% | 3.5% | 3.1% | 3.4% | 3.7% |
| Capex / operating cash flow | 102.7% | 32.1% | 15.1% | 14.9% | 12.6% | 13.4% |
| Capex / depreciation | 0.78 | 0.68 | 0.52 | 0.43 | 0.46 | 0.45 |
| Stock-based compensation / revenue | 1.9% | 1.4% | 0.5% | 0.5% | 0.5% | 0.5% |
| R&D / revenue | 8.9% | 9.4% | 9.2% | 9.4% | 9.4% | 9.9% |
| SG&A / revenue | 37.0% | 33.7% | 28.3% | 27.5% | 27.9% | 29.7% |
| Efficiency | ||||||
| Days sales outstanding | 49.6 | 56.2 | 55.3 | 52.7 | 52.6 | — |
| Days of inventory on hand | 95.7 | 90.8 | 90.1 | 89.6 | 91.4 | — |
| Days payables outstanding | 61.5 | 54.6 | 43.0 | 35.5 | 36.0 | — |
| Cash conversion cycle (days) | 83.8 | 92.4 | 102.4 | 106.8 | 108.0 | — |
| Receivables turnover | 7.36 | 6.49 | 6.60 | 6.93 | 6.94 | — |
| Payables turnover | 5.94 | 6.69 | 8.49 | 10.28 | 10.15 | — |
| Inventory turnover | 3.81 | 4.02 | 4.05 | 4.07 | 4.00 | — |
| Asset turnover | 0.58 | 0.58 | 0.60 | 0.59 | 0.58 | — |
| Average receivables | $1.13B | $1.27B | $1.24B | $1.17B | $1.18B | — |
| Average payables | $652.5M | $547.5M | $412.5M | $334.0M | $320.0M | — |
| Average inventory | $1.02B | $911.0M | $865.0M | $843.0M | $813.0M | — |
| Intangibles / total assets | 58.0% | 61.7% | 67.7% | 71.3% | 73.4% | — |
Computed from SOLV's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SOLV valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Solventum traded at 8.9 times earnings. Based on the latest twelve months, the trailing P/E is 10.5 and the forward P/E is 13.1. Solventum earned a return on equity of 38.9% and a return on invested capital of 20.4% in fiscal 2025. It ended the year with $5.0 billion of debt and $878.0 million in cash and short-term investments, net debt of $4.2 billion.
See the SOLV income statement, the SOLV chart for price history, or the SOLV stock overview for the latest quote and news.
SOLV key metrics FAQ
What is Solventum's P/E ratio?
Solventum's trailing P/E ratio is 10.5 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 13.1. At the end of fiscal 2025 it was 8.9.
What is Solventum's EV/EBITDA?
Solventum's enterprise value was 7.1 times EBITDA at the end of fiscal 2025 (enterprise value $18.0 billion, EBITDA $2.5 billion); the current EV/EBITDA is 8.1.
What is Solventum's return on equity?
Solventum's return on equity (ROE) was 38.9% in fiscal 2025: net income of $1.6 billion on average shareholders' equity of $4.0 billion.
What is Solventum's ROIC?
Solventum's return on invested capital was 20.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Solventum have?
Solventum had total debt of $5.0 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.00 and $4.2 billion of net debt (1.63 times EBITDA).
What is Solventum's free cash flow yield?
Solventum generated -$10.0 million of free cash flow in fiscal 2025, a free cash flow yield of −0.1% on its market value at year-end ($13.9 billion).
What is Solventum's current ratio?
Solventum's current ratio was 1.23 at the end of fiscal 2025: current assets were 1.23 times current liabilities.